Literature DB >> 29169496

Transfemoral Approach for Coronary Angiography and Intervention: A Collaboration of International Cardiovascular Societies.

Abdulla A Damluji1, Daniel W Nelson2, Marco Valgimigli3, Stephan Windecker3, Robert A Byrne4, Fernando Cohen5, Tejas Patel6, Emmanouil S Brilakis7, Subhash Banerjee8, Jorge Mayol9, Warren J Cantor10, Carlos E Alfonso11, Sunil V Rao12, Mauro Moscucci13, Mauricio G Cohen14.   

Abstract

OBJECTIVES: The aim of this study was to examine the current practice and use of transfemoral approach (TFA) for coronary angiography and intervention.
BACKGROUND: Wide variability exists in TFA techniques for coronary procedures.
METHODS: The authors developed a survey instrument that was distributed via e-mail lists from professional societies to interventional cardiologists from 88 countries between March and December 2016.
RESULTS: Of 987 operators, 18% were femoralists, 38% radialists, 42% both, and 2% neither. Access using femoral pulse palpation alone was preferred by 60% of operators, fluoroscopy guidance by 11%, and a combination of palpation, fluoroscopy, or ultrasound by 27%. Only 11% used micropuncture in >90% of their cases. Performing femoral angiography immediately after access was preferred by 23% and at the end of the procedure by 47%, and not done at all by 31% of operators. Hemostasis by manual compression was preferred by 50%, collagen plug vascular closure device by 31%, and suture-based vascular closure device by 11% of operators. Judkins left and right catheters were preferred for diagnostic angiography of the left (99%) and right (94%) coronary arteries. Extra backup curves (XB or EBU) were most commonly preferred for percutaneous coronary intervention of the left anterior descending (80%) and left circumflex (80%), whereas the Judkins right catheter was preferred for percutaneous coronary intervention of the right coronary artery (86%).
CONCLUSIONS: There is significant variability in preferences for femoral access technique. Even though recommended best practices advocate for fluoroscopic and ultrasound guidance, most operators use palpation alone. Femoral angiography is also not consistently used despite guideline recommendations. The lack of adoption of imaging guidance for vascular access deserves further investigation.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Keywords:  PCI; stent; survey; transfemoral

Mesh:

Year:  2017        PMID: 29169496     DOI: 10.1016/j.jcin.2017.08.035

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  7 in total

1.  Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis.

Authors:  Emily V Castle; Krishnaraj S Rathod; Oliver P Guttmann; Alice M Jenkins; Carmel D McCarthy; Charles J Knight; Constantinos O'Mahony; Anthony Mathur; Elliot J Smith; Roshan Weerackody; Adam D Timmis; Andrew Wragg; Daniel A Jones
Journal:  Heart Vessels       Date:  2018-09-27       Impact factor: 2.037

2.  Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial.

Authors:  Sanjit S Jolly; Sulaiman AlRashidi; Marc-André d'Entremont; Omar Alansari; Bradley Brochu; Laura Heenan; Elizabeth Skuriat; Jessica Tyrwhitt; Michael Raco; Michael Tsang; Nicholas Valettas; James L Velianou; Tej Sheth; Matthew Sibbald; Shamir R Mehta; Natalia Pinilla-Echeverri; Jon David Schwalm; Madhu K Natarajan; Andrew Kelly; Elie Akl; Sarah Tawadros; Mercedes Camargo; Walaa Faidi; John Bauer; Rachel Moxham; James Nkurunziza; Gustavo Dutra; Jose Winter
Journal:  JAMA Cardiol       Date:  2022-09-18       Impact factor: 30.154

3.  Predictors of femoral hematoma in patients undergoing elective coronary procedure: a trigonometric evaluation.

Authors:  Mert İlker Hayıroğlu; Tufan Çınar; Burhan Bıçakçı; İbrahim Dağaşan; Koray Demir; Muhammed Keskin; Ahmet Öz; Zafer Işılak; Nurgül Keser; Mehmet Uzun
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-17       Impact factor: 2.357

4.  Transradial versus transfemoral access for cardiac catheterization: a nationwide pilot study of training preferences and expertise in The United States.

Authors:  Khalid Changal; Mubbasher Ameer Syed; Ealla Atari; Salik Nazir; Sameer Saleem; Sajjad Gul; F N U Salman; Asad Inayat; Ehab Eltahawy
Journal:  BMC Cardiovasc Disord       Date:  2021-05-21       Impact factor: 2.298

5.  Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.

Authors:  Behnam N Tehrani; Abdulla A Damluji; Matthew W Sherwood; Carolyn Rosner; Alexander G Truesdell; Kelly C Epps; Edward Howard; Scott D Barnett; Anika Raja; Christopher R deFilippi; Charles E Murphy; Christopher M O'Connor; Wayne B Batchelor
Journal:  Catheter Cardiovasc Interv       Date:  2020-08-03       Impact factor: 2.585

6.  Ultrasound Guidance to Reduce Vascular and Bleeding Complications of Percutaneous Transfemoral Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Comparison.

Authors:  Flavien Vincent; Hugues Spillemaeker; Maéva Kyheng; Cassandre Belin-Vincent; Cédric Delhaye; Adeline Piérache; Tom Denimal; Basile Verdier; Nicolas Debry; Mouhamed Moussa; Guillaume Schurtz; Sina Porouchani; Alessandro Cosenza; Francis Juthier; Thibault Pamart; Marjorie Richardson; Augustin Coisne; Adrien Hertault; Jonathan Sobocinski; Thomas Modine; François Pontana; Alain Duhamel; Julien Labreuche; Eric Van Belle
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

7.  Contemporary Use and Outcomes of Arterial Closure Devices After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Andrew Prouse; Elise Gunzburger; Fan Yang; Justin Morrison; Javier A Valle; Ehrin J Armstrong; Stephen W Waldo
Journal:  J Am Heart Assoc       Date:  2020-02-16       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.